- call +1-201-465-4211
- email sales@mrinsights.biz
Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.
Scope of the Report:
This report studies the Parathyroid Disorders market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parathyroid Disorders market by product type and applications/end industries.
Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
The global Parathyroid Disorders market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parathyroid Disorders.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Alcon Laboratories
Amgen
Bayer Healthcare
Becton, Dickinson and Company
Eli Lilly
Ethicon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Simple Parathyroid Disorders
Complex Parathyroid Disorders
Market Segment by Applications, can be divided into
Hospitals
Clinics
Diagnostic Centers
Drug Stores
Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Parathyroid Disorders Market Overview
1.1 Product Overview and Scope of Parathyroid Disorders
1.2 Classification of Parathyroid Disorders by Types
1.2.1 Global Parathyroid Disorders Revenue Comparison by Types (2017-2023)
1.2.2 Global Parathyroid Disorders Revenue Market Share by Types in 2017
1.2.3 Simple Parathyroid Disorders
1.2.4 Complex Parathyroid Disorders
1.3 Global Parathyroid Disorders Market by Application
1.3.1 Global Parathyroid Disorders Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Drug Stores
1.3.6 Pharmacies
1.4 Global Parathyroid Disorders Market by Regions
1.4.1 Global Parathyroid Disorders Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Parathyroid Disorders Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parathyroid Disorders Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parathyroid Disorders Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Parathyroid Disorders Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parathyroid Disorders Status and Prospect (2013-2023)
1.5 Global Market Size of Parathyroid Disorders (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Parathyroid Disorders Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alcon Laboratories
2.2.1 Business Overview
2.2.2 Parathyroid Disorders Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alcon Laboratories Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.3 Amgen
2.3.1 Business Overview
2.3.2 Parathyroid Disorders Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Amgen Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer Healthcare
2.4.1 Business Overview
2.4.2 Parathyroid Disorders Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Healthcare Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.5 Becton, Dickinson and Company
2.5.1 Business Overview
2.5.2 Parathyroid Disorders Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Becton, Dickinson and Company Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Parathyroid Disorders Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ethicon
2.7.1 Business Overview
2.7.2 Parathyroid Disorders Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ethicon Parathyroid Disorders Revenue, Gross Margin and Market Share (2016-2017)
3 Global Parathyroid Disorders Market Competition, by Players
3.1 Global Parathyroid Disorders Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Parathyroid Disorders Players Market Share
3.2.2 Top 10 Parathyroid Disorders Players Market Share
3.3 Market Competition Trend
4 Global Parathyroid Disorders Market Size by Regions
4.1 Global Parathyroid Disorders Revenue and Market Share by Regions
4.2 North America Parathyroid Disorders Revenue and Growth Rate (2013-2018)
4.3 Europe Parathyroid Disorders Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Parathyroid Disorders Revenue and Growth Rate (2013-2018)
4.5 South America Parathyroid Disorders Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Parathyroid Disorders Revenue and Growth Rate (2013-2018)
5 North America Parathyroid Disorders Revenue by Countries
5.1 North America Parathyroid Disorders Revenue by Countries (2013-2018)
5.2 USA Parathyroid Disorders Revenue and Growth Rate (2013-2018)
5.3 Canada Parathyroid Disorders Revenue and Growth Rate (2013-2018)
5.4 Mexico Parathyroid Disorders Revenue and Growth Rate (2013-2018)
6 Europe Parathyroid Disorders Revenue by Countries
6.1 Europe Parathyroid Disorders Revenue by Countries (2013-2018)
6.2 Germany Parathyroid Disorders Revenue and Growth Rate (2013-2018)
6.3 UK Parathyroid Disorders Revenue and Growth Rate (2013-2018)
6.4 France Parathyroid Disorders Revenue and Growth Rate (2013-2018)
6.5 Russia Parathyroid Disorders Revenue and Growth Rate (2013-2018)
6.6 Italy Parathyroid Disorders Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Parathyroid Disorders Revenue by Countries
7.1 Asia-Pacific Parathyroid Disorders Revenue by Countries (2013-2018)
7.2 China Parathyroid Disorders Revenue and Growth Rate (2013-2018)
7.3 Japan Parathyroid Disorders Revenue and Growth Rate (2013-2018)
7.4 Korea Parathyroid Disorders Revenue and Growth Rate (2013-2018)
7.5 India Parathyroid Disorders Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Parathyroid Disorders Revenue and Growth Rate (2013-2018)
8 South America Parathyroid Disorders Revenue by Countries
8.1 South America Parathyroid Disorders Revenue by Countries (2013-2018)
8.2 Brazil Parathyroid Disorders Revenue and Growth Rate (2013-2018)
8.3 Argentina Parathyroid Disorders Revenue and Growth Rate (2013-2018)
8.4 Colombia Parathyroid Disorders Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Parathyroid Disorders by Countries
9.1 Middle East and Africa Parathyroid Disorders Revenue by Countries (2013-2018)
9.2 Saudi Arabia Parathyroid Disorders Revenue and Growth Rate (2013-2018)
9.3 UAE Parathyroid Disorders Revenue and Growth Rate (2013-2018)
9.4 Egypt Parathyroid Disorders Revenue and Growth Rate (2013-2018)
9.5 Nigeria Parathyroid Disorders Revenue and Growth Rate (2013-2018)
9.6 South Africa Parathyroid Disorders Revenue and Growth Rate (2013-2018)
10 Global Parathyroid Disorders Market Segment by Type
10.1 Global Parathyroid Disorders Revenue and Market Share by Type (2013-2018)
10.2 Global Parathyroid Disorders Market Forecast by Type (2018-2023)
10.3 Simple Parathyroid Disorders Revenue Growth Rate (2013-2023)
10.4 Complex Parathyroid Disorders Revenue Growth Rate (2013-2023)
11 Global Parathyroid Disorders Market Segment by Application
11.1 Global Parathyroid Disorders Revenue Market Share by Application (2013-2018)
11.2 Parathyroid Disorders Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
11.6 Drug Stores Revenue Growth (2013-2018)
11.7 Pharmacies Revenue Growth (2013-2018)
12 Global Parathyroid Disorders Market Size Forecast (2018-2023)
12.1 Global Parathyroid Disorders Market Size Forecast (2018-2023)
12.2 Global Parathyroid Disorders Market Forecast by Regions (2018-2023)
12.3 North America Parathyroid Disorders Revenue Market Forecast (2018-2023)
12.4 Europe Parathyroid Disorders Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Parathyroid Disorders Revenue Market Forecast (2018-2023)
12.6 South America Parathyroid Disorders Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Parathyroid Disorders Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Parathyroid Disorders Picture
Table Product Specifications of Parathyroid Disorders
Table Global Parathyroid Disorders and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
